We have a deep background in successfully deploying DEA-complaint authentication platform designed to provide EPCS-enabled care providers with identify-proofing, two-factor authentication, and auditing and reporting.
Used in conjunction with existing Prescription Monitoring Programs (PMPs), EPCS creates accountable and secure practices for those who prescribe and dispense controlled substances. EPCS allows healthcare providers to send prescriptions directly to a pharmacy electronically, eliminating the need for paper prescription pads, which can be altered, forged, or stolen to obtain prescriptions.
We believe that Less than 3 percent of all prescriptions for controlled substances are sent electronically last year. One of the major barriers to EPCS adoption in NY, NJ, MA, FL and other states across the U.S., has been the lack of technologies available to meet DEA requirements without inhibiting workflow and inconveniencing providers or patients. However, New York State has been able to overcome this barrier, and has not only adopted EPCS, but also mandated it through its Internet System for Over-Prescribing Act (I-STOP). The mandate is 03/27/2016 for State of NY which means there will be no Paper Prescription.
If you are exploring to implement ePrescription, Pls. reach out to
Sr. Director – Program Management
• Since August 27, 2013, prescribers in the state of New York are required by law to consult the Internet System for Tracking Overprescribing-Prescription Monitoring Program (I-STOP/PMP) Registry when writing prescriptions for schedule II, III, and IV controlled substances. Legislators there have also made it mandatory to use EPCS by March 27, 2016.
• Paper-based prescription systems are susceptible to fraud. Approximately one in 10 prescribers will have their DEA number forged and will need to go through the process of getting a new one at some point in their career
• In addition to security concerns, paper-based systems pose challenges for gathering metrics for Meaningful Use (MU) e-prescribing requirements
• Since the DEA first issued its guidelines, uptake of EPCS has varied by state. In 2015, there were 2.1 million EPCS, with New York accounting for 54%
• If done correctly, EPCS offers substantial benefit to health systems, physicians, and patients besides help Health systems with an opportunity to improve patient satisfaction, lower fraud risk, enforce state and federal regulations, and better meet meaningful use e-prescribing requirements
• For physicians, EPCS offers the potential to eliminate dual workflows, reduce errors and fraud, limit exposure of their DEA number, and improve patient satisfaction.
• For patients, EPCS has the potential to improve overall satisfaction, increase medication adherence, reduce trips to the physician’s office, and reduce wait times at the pharmacy
We could help Health System with 2016 ePrescribing mandate as we have deep experience with Allscripts and DrFirst EMR and ePrescribe Application.
Talk to us at 6466443049